[ Thu, Mar 13th 2025 ]: AOL
[ Thu, Mar 13th 2025 ]: WFAA
[ Thu, Mar 13th 2025 ]: Moneyweb
[ Thu, Mar 13th 2025 ]: TipRanks
[ Thu, Mar 13th 2025 ]: RochesterFirst
[ Thu, Mar 13th 2025 ]: SmartAsset
[ Thu, Mar 13th 2025 ]: Politico
[ Thu, Mar 13th 2025 ]: CNBC
[ Thu, Mar 13th 2025 ]: Audacy
[ Thu, Mar 13th 2025 ]: CNA
[ Thu, Mar 13th 2025 ]: CNN
[ Thu, Mar 13th 2025 ]: WKYT
[ Thu, Mar 13th 2025 ]: stacker
[ Thu, Mar 13th 2025 ]: Observer
[ Thu, Mar 13th 2025 ]: Euronews
[ Thu, Mar 13th 2025 ]: Bloomberg
[ Thu, Mar 13th 2025 ]: Africanews
[ Thu, Mar 13th 2025 ]: Axios
[ Thu, Mar 13th 2025 ]: Due
[ Thu, Mar 13th 2025 ]: GOBankingRates
[ Thu, Mar 13th 2025 ]: Astrofame
[ Thu, Mar 13th 2025 ]: eNCA
[ Thu, Mar 13th 2025 ]: Fortune
[ Thu, Mar 13th 2025 ]: Week99er
[ Thu, Mar 13th 2025 ]: MarketWatch
[ Thu, Mar 13th 2025 ]: Forbes
[ Thu, Mar 13th 2025 ]: Barchart
[ Thu, Mar 13th 2025 ]: Kiplinger
[ Thu, Mar 13th 2025 ]: NewcastleWorld
[ Thu, Mar 13th 2025 ]: Zawya
[ Thu, Mar 13th 2025 ]: Reuters
[ Thu, Mar 13th 2025 ]: Investopedia
[ Thu, Mar 13th 2025 ]: BusinessTech
[ Thu, Mar 13th 2025 ]: Moneycontrol
[ Thu, Mar 13th 2025 ]: Stocktwits
[ Thu, Mar 13th 2025 ]: KKTV
[ Thu, Mar 13th 2025 ]: Insider
[ Wed, Mar 12th 2025 ]: Mediaite
[ Wed, Mar 12th 2025 ]: TheWrap
[ Wed, Mar 12th 2025 ]: FXStreet
[ Wed, Mar 12th 2025 ]: CNN
[ Wed, Mar 12th 2025 ]: CNBC
[ Wed, Mar 12th 2025 ]: Yahoo
[ Wed, Mar 12th 2025 ]: CNET
[ Wed, Mar 12th 2025 ]: AOL
[ Wed, Mar 12th 2025 ]: Fortune
[ Wed, Mar 12th 2025 ]: Forbes
[ Wed, Mar 12th 2025 ]: Reuters
Mallinckrodt and Endo plan merger as they look to recover from opioid litigation
- 🞛 This publication is a summary or evaluation of another publication
- 🞛 This publication contains editorial commentary or bias from the source
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three.
Read the Full MarketWatch Article at:
[ https://www.msn.com/en-us/money/general/mallinckrodt-and-endo-plan-merger-as-they-look-to-recover-from-opioid-litigation/ar-AA1AQiaW ]